Acrylamide: The Lab Reagent at the Center of a Poisoning Case
A poisoning case involving a graduate student has drawn attention to one of the least remarkable bottles in any molecular biology lab: acrylamide, a white crystalline powder that appears in nearly every Western blot protocol and is handled with gloves and a fume hood rather than alarm.
According to reports dated October 13, 32-year-old Aili Wang, a doctoral candidate in biology, is accused of repeatedly putting a toxic chemical into a colleague’s coffee pot. The colleague developed numbness in the hands and feet, weakness in the legs, fatigue and insomnia — symptoms consistent with nerve damage — and has not recovered. Wang was reportedly preparing to return to China on October 6.
Acrylamide is familiar to anyone who has run a protein gel. Mixed with water and a crosslinker, it polymerizes into the mesh that separates proteins by size, a workhorse technique in cell and molecular biology. In its unpolymerized powder form it is a known neurotoxin, and it is also classified as a probable human carcinogen. Chronic exposure can cause tingling, loss of balance and muscle weakness that may take months to fade.
The substance is not exotic or tightly controlled in most labs. It sits in a chemical cabinet alongside dozens of other reagents, ordered through ordinary supply channels, weighed out at the bench and recorded in a shared inventory sheet if the institution is diligent. Because it is so routine, few laboratories treat it as a candidate weapon, and access is often broad.
The case sits in a wider pattern in which academic labs, built around openness and shared equipment, are poorly suited to guarding against a colleague who intends harm. Shared coffee machines, communal refrigerators and unlocked reagent shelves are normal. Researchers in the United States, where the case is being handled, have followed it closely, partly because the accused and the victim were peers in the same program.
For global readers, the story is also a reminder that the most dangerous things in a lab are often the most ordinary. Acrylamide’s hazards are well documented in safety data sheets, and standard precautions — gloves, a mask, weighing powder in a hood — are designed to protect the person handling it, not to stop someone deliberately misusing it.
The practical questions that follow are institutional rather than chemical. How do labs reconcile reagent inventories against usage? What happens when a doctoral defense fails and a student’s visa clock is running out? And how quickly do symptoms of nerve damage get linked back to a shared kitchen? The answers will shape how universities think about trust inside the spaces where science is done.
Acrylamide will keep appearing in Western blots either way. What changes is whether the bottle is treated as a hazard to be managed or a risk to be watched.